In addition, plasma apoA-IV did not correlate with TG, CE and FC levels in SIRS/sepsis patients when patients with liver cirrhosis were excluded, also ruling out a role for apoA-IV in dyslipidemia in sepsis. This evidence concerns the gene APOA4 and systemic inflammatory response syndrome.